✦ LIBER ✦

Pretransplant emergence of lamivudine mutants does not enhance the risk of HBV reactivation

✍ Scribed by Raffaella Romeo; Lucio Caccamo; Giorgio Rossi; Floriana Facchetti; Luigi Rainiero Fassati; Massimo Colombo

Book ID: 118565599
Publisher: Elsevier Science
Year: 2002
Tongue: English
Weight: 209 KB
Volume: 36
Category: Article
ISSN: 0168-8278
DOI: 10.1016/s0168-8278(02)80683-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Serum HBV RNA is a predictor of early em

Serum HBV RNA is a predictor of early emergence of the YMDD mutant in patients treated with lamivudine

✍ Tsuyoshi Hatakeyama; Chiemi Noguchi; Nobuhiko Hiraga; Nami Mori; Masataka Tsuge; 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 421 KB

Lamivudine (LAM) is a nucleoside analogue widely used for the treatment of chronic hepatitis B virus (HBV) infection. Emergence of resistant strains with amino acid substitutions in the tyrosine-methionine-aspartate-aspartate (YMDD) motif of reverse transcriptase is a serious problem in patients on

Perioperative hypothermia does not enhan

Perioperative hypothermia does not enhance the risk of cancer dissemination

✍ Yüksel Yücel; Murat Barlan; Rainer Lenhardt; Andrea Kurz; Daniel I. Sessler 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 161 KB

503 The selection of the patients with r

503 The selection of the patients with risk of developing hepatic failure after the emergence of lamivudine-resistant HBV

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 123 KB

370 HBV REACTIVATION FOLLOWING CHEMOTHER

370 HBV REACTIVATION FOLLOWING CHEMOTHERAPY IN HBSAG NEGATIVE / HBCAB POSITIVE PATIENTS IS ASSOCIATED WITH NON-A GENOTYPE AND THE EMERGENCE OF HBSAG MUTANTS

✍ P. Borentain; P. Colson; D. Coso; A. Motte; E. Bories; C. Chabanon; C. Tamalet; 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 40 KB

Tirofiban therapy does not increase the

Tirofiban therapy does not increase the risk of hemorrhage after emergency coronary surgery

✍ Michele Genoni; Daniela Zeller; O. Bertel; M. Maloigne; M. Turina 📂 Article 📅 2001 🏛 CTSNet 🌐 English ⚖ 57 KB

Fatal postlymphoma chemotherapy hepatiti

Fatal postlymphoma chemotherapy hepatitis B reactivation secondary to the emergence of a YMDD mutant strain with lamivudine resistance in a noncirrhotic patient

✍ Joanna K. Law; Jaber Al Ali; P. Richard Harrigan; Christopher H. Sherlock; Kerry 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 85 KB 👁 2 views